Related Experiment Video
Updated: Jul 26, 2025
08:30
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
13.1K
Adherence and Persistence to Medical Therapy in Glaucoma: An Overview
Luciano Quaranta1, Alessio Novella2, Mauro Tettamanti2
1Centro Oculistico Italiano, Brescia, Italy. lquaranta@centroculisticoitaliano.it.
Ophthalmology and Therapy
|June 13, 2023
Summary
Patient adherence to glaucoma eye drops is often low, impacting treatment success and potentially leading to vision loss. Educating patients on glaucoma and adherence is crucial for better outcomes and reduced healthcare costs.
Area of Science:
- Ophthalmology
- Neuroscience
Background:
- Glaucoma is a progressive optic neuropathy causing vision loss.
- Elevated intraocular pressure (IOP) is a key modifiable risk factor for glaucoma.
- Effective IOP control is vital for preventing glaucoma progression.
Purpose of the Study:
- To analyze and discuss factors influencing patient adherence to glaucoma medications.
- To highlight the importance of patient education in improving treatment persistence.
Main Methods:
- Review of existing epidemiological studies and clinical trials on glaucoma treatment adherence.
- Analysis of factors contributing to medication non-adherence in chronic conditions.
Main Results:
- Glaucoma patients exhibit low adherence and persistence rates with prescribed eye drops.
- Poor adherence is linked to disease progression, increased complications, and higher healthcare expenses.
- Patient education on glaucoma and adherence benefits is fundamental.
Conclusions:
- Improving patient education is essential for enhancing adherence to glaucoma therapy.
- Better adherence can prevent visual disability and reduce healthcare costs associated with glaucoma management.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
491
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
491
01:25Glaucoma: Overview
633
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
633
01:28Angle Closure Glaucoma: Treatment
578
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
578
01:28Drug Therapy
74
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
74
01:15Diabetes: Management and Pharmacotherapy
319
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
319
01:24Rational Dosage Regimen: Maintenance Dose and Loading Dose
4.2K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.2K